OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
Nvidia’s Rosy Forecast Shows Chipmaker Benefiting From AI Boom
Elon Musk trains with UFC legend ahead of Mark Zuckerberg fight
AeroVironment, Inc. to Acquire Tomahawk Robotics
Qarar and Biz2X Partner to Launch the First Cloud-Based SME Lending Platform in Saudi Arabia
Tech Industry Dodges California Social Media Addiction Bill
Best Buy Tops Profit Estimates Despite Continuing Sales Slump
OpenAI in talks to sell shares at $86 billion valuation - Bloomberg News
Omegle anonymous chat app shuts down after being used for ‘unspeakably heinous crimes’